Exploring Potential Causal Genetic Variants and Genes for Endometrial Cancer: Open Targets Genetics, Mendelian Randomization, and Multi-tissue Transcriptome-wide Association Analysis

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2024 Dec 19

PMID 39697733

Authors

Guorui Zhang

Su Mao

Guangwei Yuan

Yang Wang

Jingyun Yang

Yuxin Dai

Affiliations

Soon will be listed here.

Abstract

Background: Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with incidence rates continuing to rise globally. However, the precise mechanisms underlying EC pathogenesis remain largely unexplored. This study aims to prioritize genes associated with EC by leveraging multi-omics data through various bioinformatic methods.

Methods: We utilized the Open Targets Genetics (OTG) database to pinpoint potential causal variants and target genes for EC. To explore the pleiotropic effects of gene expression on EC, we applied the Summary-based Mendelian Randomization (SMR) using summary data from a genome-wide association study (GWAS) on EC and expression quantitative trait loci (eQTL) data from the Consortium for the Architecture of Gene Expression (CAGE). We also conducted a cross-tissue transcriptome-wide association study (TWAS) employing sparse canonical correlation analysis (sCCA). Results from the sCCA TWAS and single-tissue TWAS for 22 tissues were combined using the aggregated Cauchy association test (sCCA + ACAT) to identify genes with cis-regulated expression levels linked to EC.

Results: The OTG database recognized 15 genomic loci showing independent association with EC. Gene prioritization highlighted nine genes with relatively high locus-to-gene (L2G) scores (≥0.5), the majority of which aligned with those identified using the closest gene. Colocalization analysis identified 11 additional genes at these loci. Our SMR analysis revealed two genes, and , exhibiting a significant pleiotropic association with EC. Cross-tissue TWAS identified 31 genes whose expression was significantly associated with EC after correction for multiple testing, with four genes (, , , and ) also confirmed by gene colocalization in the OTG analysis.

Conclusions: We confirmed the involvement of in the pathogenesis of EC and identified several other genes that may contribute to EC development. These findings offer new insights into the genetic mechanisms underlying EC and may inform future research and therapeutic strategies.

References

Zhu Z, Zhang F, Hu H, Bakshi A, Robinson M, Powell J . Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016; 48(5):481-7. DOI: 10.1038/ng.3538. View

Cheng S, Zhang X, Huang N, Qiu Q, Jin Y, Jiang D . Down-regulation of S100A9 inhibits osteosarcoma cell growth through inactivating MAPK and NF-κB signaling pathways. BMC Cancer. 2016; 16:253. PMC: 4810516. DOI: 10.1186/s12885-016-2294-1. View

Painter J, OMara T, Batra J, Cheng T, Lose F, Dennis J . Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Hum Mol Genet. 2014; 24(5):1478-92. PMC: 4321445. DOI: 10.1093/hmg/ddu552. View

Cheung L, Hennessy B, Li J, Yu S, Myers A, Djordjevic B . High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cancer Discov. 2011; 1(2):170-85. PMC: 3187555. DOI: 10.1158/2159-8290.CD-11-0039. View

Ren X, Liang J, Zhang Y, Jiang N, Xu Y, Qiu M . Single-cell transcriptomic analysis highlights origin and pathological process of human endometrioid endometrial carcinoma. Nat Commun. 2022; 13(1):6300. PMC: 9588071. DOI: 10.1038/s41467-022-33982-7. View

Li X, Rees J, Xue P, Zhang H, Hamaia S, Sanderson B . New insights into the DT40 B cell receptor cluster using a proteomic proximity labeling assay. J Biol Chem. 2014; 289(21):14434-47. PMC: 4031500. DOI: 10.1074/jbc.M113.529578. View

Wan L, Wang Y, Zhang Z, Wang J, Niu M, Wu Y . Elevated TEFM expression promotes growth and metastasis through activation of ROS/ERK signaling in hepatocellular carcinoma. Cell Death Dis. 2021; 12(4):325. PMC: 7997956. DOI: 10.1038/s41419-021-03618-7. View

Shisler R, Sinnott J, Wang V, Hebert C, Salani R, Felix A . Life after endometrial cancer: A systematic review of patient-reported outcomes. Gynecol Oncol. 2017; 148(2):403-413. DOI: 10.1016/j.ygyno.2017.11.007. View

Xu J, Xu T, Wu B, Ye Y, You X, Shu X . Structure of sorting nexin 11 (SNX11) reveals a novel extended phox homology (PX) domain critical for inhibition of SNX10-induced vacuolation. J Biol Chem. 2013; 288(23):16598-16605. PMC: 3675595. DOI: 10.1074/jbc.M112.449306. View

10.

Ghoussaini M, Mountjoy E, Carmona M, Peat G, Schmidt E, Hercules A . Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 2020; 49(D1):D1311-D1320. PMC: 7778936. DOI: 10.1093/nar/gkaa840. View

11.

Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx B . Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016; 48(3):245-52. PMC: 4767558. DOI: 10.1038/ng.3506. View

12.

Wu R, Li D, Tang Q, Wang W, Xie G, Dou P . A Novel Peptide from Vespa ducalis Induces Apoptosis in Osteosarcoma Cells by Activating the p38 MAPK and JNK Signaling Pathways. Biol Pharm Bull. 2018; 41(4):458-464. DOI: 10.1248/bpb.b17-00449. View

13.

Ali A . Risk factors for endometrial cancer. Ceska Gynekol. 2013; 78(5):448-59. View

14.

Lax S, Kendall B, Tashiro H, Slebos R, Hedrick L . The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways. Cancer. 2000; 88(4):814-24. View

15.

Chandra M, Chin Y, Mas C, Feathers J, Paul B, Datta S . Classification of the human phox homology (PX) domains based on their phosphoinositide binding specificities. Nat Commun. 2019; 10(1):1528. PMC: 6449406. DOI: 10.1038/s41467-019-09355-y. View

16.

Tang X, Wang J, Tao H, Yuan L, Du G, Ding Y . Regulatory patterns analysis of transcription factor binding site clustered regions and identification of key genes in endometrial cancer. Comput Struct Biotechnol J. 2022; 20:812-823. PMC: 8844752. DOI: 10.1016/j.csbj.2022.01.014. View

17.

OMara T, Glubb D, Painter J, Cheng T, Dennis J, Attia J . Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. Endocr Relat Cancer. 2015; 22(5):851-61. PMC: 4559752. DOI: 10.1530/ERC-15-0319. View

18.

Zhang Y, Hurson A, Zhang H, Pal Choudhury P, Easton D, Milne R . Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nat Commun. 2020; 11(1):3353. PMC: 7335068. DOI: 10.1038/s41467-020-16483-3. View

19.

OMara T, Spurdle A, Glubb D . Analysis of Promoter-Associated Chromatin Interactions Reveals Biologically Relevant Candidate Target Genes at Endometrial Cancer Risk Loci. Cancers (Basel). 2019; 11(10). PMC: 6826789. DOI: 10.3390/cancers11101440. View

20.

OMara T, Glubb D, Amant F, Annibali D, Ashton K, Attia J . Identification of nine new susceptibility loci for endometrial cancer. Nat Commun. 2018; 9(1):3166. PMC: 6085317. DOI: 10.1038/s41467-018-05427-7. View